Cent Eur J Public Health 2003, 11(Supplement):S54-S61

The 2001 serological survey in the Czech Republic - Viral hepatitis

Němeček V., Částková J., Fritz P., Linhartová A., ©vandová E., ©rámová H., Kříľ B.
Centre of Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic

Within serological surveys 2001, prevalence of markers of hepatitis viruses A (anti-HAV), B (anti-HBc, HBsAg, anti-HBs) and for the first time also C (anti-HCV) was investigated. Sera were collected in 2001and tested by respective kits AxSYM, Abbott.
HAV: 2,623 sera were tested for the presence of anti-HAV antibodies. Comparison with serological surveys of 1984 and 1996 revealed again shifts of the age prevalence curve for anti-HAV antibodies towards higher age groups corresponding to time intervals between epidemiological surveys. High prevalence rates of anti-HAV antibodies (more than 20 %) were only found for the population age groups who lived in the period of high incidence of VHA, i.e. up to 1965. The prevalence of anti-HAV antibodies increased by about 5-10 % in the population under 20 years of age, the increase being significant and assumingly attributable to vaccination against VHA, and remained the same as in 1996 in the age group 20-29 years.
HBV: 2,568 sera were tested for the presence of anti-HBc antibodies and 76 reactive specimens were further tested for the presence of HBsAg and anti-HBs antibodies. The prevalence of anti-HBc antibodies continuously increases with age. The total prevalence of anti-HBc antibodies calculated for the Czech population is 5.59 % compared to 6.95 % recorded in 1996. The calculated prevalence rate of HBsAg is 0.56 % and that of anti-HBs antibodies is 3.99 % for the non-vaccinee population.
HCV: The prevalence rate of anti-HCV antibodies was 0.2 % with 6 out of 2,950 sera testing positive. Age dependence could not be assessed because of the small number of positive persons. HCV infection is known to afflict high-risk groups, likely to escape a general serological survey, rather than the normal population.

Keywords: hepatitis A, hepatitis B, hepatitis C, serological surveys, epidemiology

Published: December 1, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němeček V, Částková J, Fritz P, Linhartová A, ©vandová E, ©rámová H, Kříľ B. The 2001 serological survey in the Czech Republic - Viral hepatitis. Cent Eur J Public Health. 2003;11(Supplement):S54-61. PubMed PMID: 15080261.
Download citation